Other Events ·
At its 2026 Annual Meeting of Stockholders held on June 9, 2026, Voyager Therapeutics, Inc. stockholders approved an…
VYGRVoyager Therapeutics, Inc.
At its 2026 Annual Meeting of Stockholders held on June 9, 2026, Voyager Therapeutics, Inc. stockholders approved an amendment to the Certificate of Incorporation to increase the number of authorized shares of capital stock from 125,000,000 to 245,000,000 and common stock from 120,000,000 to 240,000,000. Voyager Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for genetic diseases.